Ramaphosa hails Lenacapavir roll out as turning point in HIV fight
A twice-yearly injectable HIV prevention drug has arrived in South Africa. The rollout of the drug, lenacapavir, is underway in the country that needs it the most, about a-year-and-a-half after US aid cuts hit some of its HIV programmes.
South Africa has officially launched the distribution of lenacapavir, a groundbreaking injectable medication designed to prevent HIV infection. Administered only twice a year, this new treatment offers a more convenient alternative to daily oral preventative pills. President Cyril Ramaphosa has characterized the introduction of this drug as a significant milestone in the nation's long-standing battle against the virus. The rollout comes at a critical juncture, arriving roughly eighteen months after the country experienced a reduction in international funding for its public health initiatives. Health officials hope this innovation will help stabilize and improve HIV prevention outcomes across the region.
The introduction of a long-acting injectable drug represents a major shift in HIV prevention strategies, potentially overcoming adherence challenges associated with daily medication regimens in heavily impacted areas.
📌 Kaynak
Bu özet Africanews kaynağından otomatik derlenmiştir. Tamamı için orijinal habere gidin.
Orijinal haberi oku →